A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
BACKGROUND: β-Microseminoprotein (MSP) is one of the three most abundantly secreted proteins of the prostate and has been suggested as a biomarker for prostate cancer risk. A common variant, rs10993994, in the 5' region of the gene that encodes MSP (MSMB) has recently been identified as a risk...
Váldodahkkit: | Waters, K, Stram, DO, Le Marchand, L, Klein, R, Valtonen-André, C, Peltola, M, Kolonel, L, Henderson, B, Lilja, H, Haiman, C |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
2010
|
Geahča maid
-
Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations.
Dahkki: Haiman, C, et al.
Almmustuhtton: (2013) -
Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.
Dahkki: Xu, X, et al.
Almmustuhtton: (2010) -
beta-Microseminoprotein binds CRISP-3 in human seminal plasma.
Dahkki: Udby, L, et al.
Almmustuhtton: (2005) -
Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
Dahkki: Liisa Sjöblom, et al.
Almmustuhtton: (2016-01-01) -
Beta-microseminoprotein in serum correlates with the levels in seminal plasma of young, healthy males.
Dahkki: Valtonen-André, C, et al.
Almmustuhtton: (2008)